The use of recombinant antibodies in proteomics
Current Opinion in Biotechnology, ISSN: 0958-1669, Vol: 11, Issue: 5, Page: 445-449
2000
- 115Citations
- 73Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations115
- Citation Indexes109
- 109
- CrossRef84
- Patent Family Citations6
- Patent Families6
- Captures73
- Readers73
- 73
Review Description
Recombinant antibodies are becoming increasingly important in the field of proteomics. Recent advances include the development of large phage–antibody libraries that contain high-affinity binders to almost any target protein, and new methods for high-throughput selection of antibody–antigen interactions. Coupled with a range of new screening technologies that use high-density antibody arrays to identify differentially expressed proteins, these antibody libraries can be applied to whole proteome analysis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0958166900001336; http://dx.doi.org/10.1016/s0958-1669(00)00133-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0033781431&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11024361; https://linkinghub.elsevier.com/retrieve/pii/S0958166900001336; http://linkinghub.elsevier.com/retrieve/pii/S0958166900001336; http://api.elsevier.com/content/article/PII:S0958166900001336?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0958166900001336?httpAccept=text/plain; http://dx.doi.org/10.1016/s0958-1669%2800%2900133-6; https://dx.doi.org/10.1016/s0958-1669%2800%2900133-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know